Nevertheless, a recent meta-analysis showed that CTCs expressing thyroid-stimulating hormone receptor (TSHR), rather than EpCAM, are a reliable marker for the diagnosis of patients with thyroid cancer recurrence or metastasis [150]. Here, TSHR is linked to thyroid cancer.